The news cycle has hit overdrive in the UK ahead of a frenetic couple of weeks that include the Autumn Budget, a Comprehensive Spending Review and the COP26 con 26 October 2021
Carima Andrady, senior regulatory writer at PharmaLex, provides an Expert View on a key consideration when seeking to secure an Orphan Drug Designation (ODD) in 8 October 2021
Uwe Trinks, global practice lead for pharmacovigilance technologies, IQVIA, provides an Expert View on how the pharmaceutical industry can make a success of new 21 September 2021
Kees Melief, chief scientific officer of ISA Pharmaceuticals, provides an Expert View on why therapeutic cancer vaccines will be a success following many years 3 September 2021
Eva Marchese, Abhishek Kumar and Kees Chamberlain from Charles River Associates examine how the COVID-19 pandemic is expected to impact payers’ management of ph 26 August 2021
Raman Sehgal, the founder of ramarketing, provides an Expert View on how pharmaceutical and life sciences businesses can market themselves in the post-pandemic 10 August 2021
An Expert View on the pros and cons of intellectual property (IP) protections in the pharmaceutical sector from White & Case partners' competition lawyer.James 20 July 2021
Merlin Piscitelli, chief revenue officer for EMEA at Datasite, provides an Expert View on M&A trends and predictions for deal-making in life sciences, and some 1 July 2021
Over the past few decades, there’s hardly a sector that has not been revolutionised by technology in some way, shape or form. When we think about tech innovatio 22 June 2021
In an environment with continued pricing pressure biopharma executives are asking themselves: Can we discover and develop new medicines that improve patient out 17 June 2021
An Expert View from Mark Doyle, co-founder of UK company The Method and creator of A Life in a Day experience, which seeks to support the pharmaceutical and hea 7 June 2021
AJ Ploszay, VP of digital strategy, IQVIA, provides an Expert View on how the precedent for consumer buying set by companies like Amazon, further accelerated by 20 May 2021
An Expert View from Manjit Singh, chairman of the Pharmaceutical Supply Chain Initiative, which tries to foster responsible supply chains, highlighting the issu 14 May 2021
Catherine Owen, senior vice president of major markets at Bristol Myers Squibb, provides an Expert View on why increasing female representation on corporate boa 7 May 2021
Nicola Mahy, director at Align Strategy, makes the case for an integrated evidence plan to maximize patient access to a brand in an Expert View piece. 21 April 2021
Hannah Schofield, associate at Hogan Lovells, considers the option of utilizing blockchain technology for accurate tracking and monitoring in an Expert View pie 7 April 2021
Debbie Bowen-Heaton's, partner at Oliver Wight, provides an Expert View on how companies can prepare for the disruption Amazon's arrival in Europe's pharmaceuti 23 March 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.